Trials / Unknown
UnknownNCT05145803
Asymptomatic and Pre-symptomatic Transmission of SARS-CoV-2 in a Community Congregant Setting
Asymptomatic and Pre-symptomatic Transmission of SARS-CoV-2 in a Community Congregant Setting: a Study to Understand How Infection Control Practices Can Mitigate Exposure Risks
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,300 (estimated)
- Sponsor
- Colorado School of Public Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The overall aim of this study is to measure how transmission of COVID-19 occurs in communities - including the role of super spreaders and/or identifying conditions that may increase transmission risk, with a focus on congregant situations. In order to identify how presence of symptoms and behavior affects the transmissibility of the virus, the investigators will measure SARS-CoV-2 in exhaled breath of asymptomatic and symptomatic persons using polyvinyl alcohol (PVA) test strips embedded in face masks (Face Mask Sampling- "FMS") - an innovative, non-invasive method for detection of SARS-CoV-2 in exhaled air.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Polyvinylalcohol strip [diagnostic] | The investigators will measure SARS-CoV-2 in exhaled breath of asymptomatic and symptomatic persons using PVA test strips embedded in face masks (FMS) - an innovative, non-invasive method for detection of SARS-CoV-2 in exhaled air. Utilizing this approach, the study aims to utilize the test results extracted from the masks to identify risk factors for SARS-CoV-2 transmission and timing of infectious period in exposed people (pre-symptomatic, asymptomatic, and symptomatic). |
Timeline
- Start date
- 2021-03-15
- Primary completion
- 2022-03-09
- Completion
- 2022-09-01
- First posted
- 2021-12-06
- Last updated
- 2021-12-20
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05145803. Inclusion in this directory is not an endorsement.